Related Experiment Video
Updated: Jul 18, 2026
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Multidrug resistance protein expression of adult T-cell leukemia/lymphoma
Takeshi Yasunami1, Yan-hua Wang, Kazue Tsuji
1Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Abstract:
In adult T-cell leukemia/lymphoma (ATL), it is difficult to achieve remission and the reason for the resistance to chemotherapeutic agents may be linked to the presence of multidrug resistance (MDR) proteins. Lung resistance-related protein (LRP), multidrug resistance-associated protein and P-glycoprotein are three MDR proteins which we examined in ATL cells using multiparametric flow cytometry and real-time RT-PCR. LRP was highly expressed and suppressing LRP function increased doxorubicin accumulation in nuclei. This indicates LRP may be contributing to drug resistance in ATL patients, and the suppression of LRP function could be a new strategy for ATL treatment.
Insights
Multidrug resistance (MDR) proteins like Lung resistance-related protein (LRP) contribute to poor outcomes in adult T-cell leukemia/lymphoma (ATL). Suppressing LRP function may enhance chemotherapy effectiveness in ATL treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Adult T-cell leukemia/lymphoma (ATL) is challenging to treat, with frequent resistance to chemotherapy.
- Multidrug resistance (MDR) proteins are implicated in treatment failure in various cancers, including ATL.
Purpose of the Study:
- To investigate the role of MDR proteins, specifically Lung resistance-related protein (LRP), in drug resistance in ATL.
- To explore the potential of targeting LRP as a therapeutic strategy for ATL.
Main Methods:
- Analysis of MDR protein expression (LRP, MRP, P-gp) in ATL cells using multiparametric flow cytometry.
- Quantification of MDR protein gene expression via real-time RT-PCR.
- Assessment of doxorubicin accumulation in ATL cell nuclei following LRP function suppression.
Main Results:
- Lung resistance-related protein (LRP) was found to be highly expressed in ATL cells.
- Inhibition of LRP function led to increased nuclear accumulation of doxorubicin.
- These findings suggest LRP actively contributes to chemotherapy resistance in ATL.
Conclusions:
- Lung resistance-related protein (LRP) plays a significant role in mediating drug resistance in adult T-cell leukemia/lymphoma (ATL).
- Targeting and suppressing LRP function presents a promising novel therapeutic strategy for improving treatment outcomes in ATL patients.
